Publikationen, an denen er mitarbeitet Luis Alberto González Guijarro (27)

2024

  1. Abnormal Histopathological Expression of Klotho, Ferroptosis, and Circadian Clock Regulators in Pancreatic Ductal Adenocarcinoma: Prognostic Implications and Correlation Analyses

    Biomolecules, Vol. 14, Núm. 8

  2. Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice

    Medicina (Lithuania), Vol. 60, Núm. 1

2023

  1. Evidence of Increased Oxidative Stress in the Placental Tissue of Women Who Suffered an Episode of Psychosis during Pregnancy

    Antioxidants, Vol. 12, Núm. 1

  2. Prognostic Value of Malondialdehyde (MDA) in the Temporal Progression of Chronic Spinal Cord Injury

    Journal of Personalized Medicine, Vol. 13, Núm. 4

  3. The Placentas of Women Who Suffer an Episode of Psychosis during Pregnancy Have Increased Lipid Peroxidation with Evidence of Ferroptosis

    Biomolecules, Vol. 13, Núm. 1

  4. Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer

    Journal of Personalized Medicine, Vol. 13, Núm. 2

  5. Women with psychotic episodes during pregnancy show increased markers of placental damage with Tenney-Parker changes

    Histology and Histopathology, Vol. 38, Núm. 10, pp. 1109-1118

2022

  1. An Updated View of the Importance of Vesicular Trafficking and Transport and Their Role in Immune-Mediated Diseases: Potential Therapeutic Interventions

    Membranes, Vol. 12, Núm. 6

  2. Chronic Venous Disease during Pregnancy Causes a Systematic Increase in Maternal and Fetal Proinflammatory Markers

    International journal of molecular sciences, Vol. 23, Núm. 16

  3. Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer

    Cancers, Vol. 14, Núm. 8

  4. Contribution of the Elastic Component and Venous Wall Arterialization in Patients with Venous Reflux

    Journal of Personalized Medicine, Vol. 12, Núm. 2

  5. Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity

    Biomedicines, Vol. 10, Núm. 3

  6. Gut Microbiota Metabolites in Major Depressive Disorder—Deep Insights into Their Pathophysiological Role and Potential Translational Applications

    Metabolites, Vol. 12, Núm. 1

  7. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies

    Current Oncology, Vol. 29, Núm. 4, pp. 2442-2453

  8. Prognostic role of IRS-4 in the survival of patients with pancreatic cancer

    Histology and histopathology, Vol. 37, Núm. 5, pp. 449-459

  9. Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine

    Frontiers in Oncology, Vol. 12

2021

  1. Abnormal proinflammatory and stressor environmental with increased the regulatory cellular igf-1/papp-a/ stc and wnt-1/β-catenin canonical pathway in placenta of women with chronic venous disease during pregnancy

    International Journal of Medical Sciences, Vol. 18, Núm. 13, pp. 2814-2827

  2. Actinomycin d arrests cell cycle of hepatocellular carcinoma cell lines and induces p53-dependent cell death: A study of the molecular mechanism involved in the protective effect of irs-4

    Pharmaceuticals, Vol. 14, Núm. 9

  3. An updated review of sars-cov-2 vaccines and the importance of effective vaccination programs in pandemic times

    Vaccines, Vol. 9, Núm. 5

  4. Nutritional components in western diet versus mediterranean diet at the gut microbiota-immune system interplay. implications for health and disease

    Nutrients, Vol. 13, Núm. 2, pp. 1-53